CoreAge Rx vs AlyveRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and AlyveRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 69 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make AlyveRx a bad call — it's best for readers who will verify the exact formulation, full payment and refund contact before choosing an advertised starting offer. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | AlyveRx |
|---|---|---|
| Brief Score | 94/100 (A) | 69/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm supply and full charge From $183/mo advertised. Vial volume alone does not establish strength, supplied weeks or payment commitment. Full price detailsCompounded semaglutide offered; complete current quote and term unknown; product advertises from $183/month; earlier listing: From $183/mo (all doses, compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm current price The product’s $283 starting display differs from a shared $329 display; obtain the selected full quote. Full price detailsCompounded tirzepatide offered; complete current quote unknown because product and shared price displays differ; earlier listing: From $249/mo (all doses, compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Medication-specific state and pharmacy eligibility requires confirmation |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
AlyveRx: Product cards show semaglutide from $183 and tirzepatide from $283, while shared tirzepatide displays show $329. Complete current quotes remain unconfirmed.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.